Drug, Device Makers Cheer As FDA Punts Off-Label Policy
The U.S. Food and Drug Administration on Friday once again delayed a controversial new policy related to off-label promotion, drawing cheers from drug and device makers that have decried the agency's...To view the full article, register now.
Already a subscriber? Click here to view full article